Per O Jansson

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G. Babiker, Laura Richert et al. · The Lancet · 2014 · 176 citations

Pharmacy, Infectious Diseases, Pharmacology +13

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

Ruth Lynfield, Marcelo Losso, Richard T. Davey et al. · Open Forum Infectious Diseases · 2017 · 18 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6

Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy

Katherine Huppler Hullsiek, Jonathan Kagan, Nicole Engen et al. · Therapeutic Innovation & Regulatory Science · 2014 · 17 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +11